183 related articles for article (PubMed ID: 8555936)
1. Third generation oral contraceptives and risk of myocardial infarction: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Lewis MA; Spitzer WO; Heinemann LA; MacRae KD; Bruppacher R; Thorogood M
BMJ; 1996 Jan; 312(7023):88-90. PubMed ID: 8555936
[TBL] [Abstract][Full Text] [Related]
2. The use of oral contraceptives and the occurrence of acute myocardial infarction in young women. Results from the Transnational Study on Oral Contraceptives and the Health of Young Women.
Lewis MA; Heinemann LA; Spitzer WO; MacRae KD; Bruppacher R
Contraception; 1997 Sep; 56(3):129-40. PubMed ID: 9347202
[TBL] [Abstract][Full Text] [Related]
3. Third generation oral contraceptives and risk of venous thromboembolic disorders: an international case-control study. Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Spitzer WO; Lewis MA; Heinemann LA; Thorogood M; MacRae KD
BMJ; 1996 Jan; 312(7023):83-8. PubMed ID: 8555935
[TBL] [Abstract][Full Text] [Related]
4. Case-control study of oral contraceptives and risk of thromboembolic stroke: results from International Study on Oral Contraceptives and Health of Young Women.
Heinemann LA; Lewis MA; Thorogood M; Spitzer WO; Guggenmoos-Holzmann I; Bruppacher R
BMJ; 1997 Dec; 315(7121):1502-4. PubMed ID: 9420491
[TBL] [Abstract][Full Text] [Related]
5. Oral contraceptives and myocardial infarction: results of the MICA case-control study.
Dunn N; Thorogood M; Faragher B; de Caestecker L; MacDonald TM; McCollum C; Thomas S; Mann R
BMJ; 1999 Jun; 318(7198):1579-83. PubMed ID: 10364115
[TBL] [Abstract][Full Text] [Related]
6. First-time use of newer oral contraceptives and the risk of venous thromboembolism.
Suissa S; Blais L; Spitzer WO; Cusson J; Lewis M; Heinemann L
Contraception; 1997 Sep; 56(3):141-6. PubMed ID: 9347203
[TBL] [Abstract][Full Text] [Related]
7. The differential risk of oral contraceptives: the impact of full exposure history.
Lewis MA; MacRae KD; Kühl-Habichl D; Bruppacher R; Heinemann LA; Spitzer WO
Hum Reprod; 1999 Jun; 14(6):1493-9. PubMed ID: 10359554
[TBL] [Abstract][Full Text] [Related]
8. Oral contraceptives and the risk of myocardial infarction.
Tanis BC; van den Bosch MA; Kemmeren JM; Cats VM; Helmerhorst FM; Algra A; van der Graaf Y; Rosendaal FR
N Engl J Med; 2001 Dec; 345(25):1787-93. PubMed ID: 11752354
[TBL] [Abstract][Full Text] [Related]
9. Modeled estimates of myocardial infarction and venous thromboembolic disease in users of second and third generation oral contraceptives.
Schwingl PJ; Shelton J
Contraception; 1997 Mar; 55(3):125-9. PubMed ID: 9114999
[TBL] [Abstract][Full Text] [Related]
10. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. The Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Lewis MA; Heinemann LA; MacRae KD; Bruppacher R; Spitzer WO
Contraception; 1996 Jul; 54(1):5-13. PubMed ID: 8804801
[TBL] [Abstract][Full Text] [Related]
11. Risk of venous thromboembolism among users of third generation oral contraceptives compared with users of oral contraceptives with levonorgestrel before and after 1995: cohort and case-control analysis.
Jick H; Kaye JA; Vasilakis-Scaramozza C; Jick SS
BMJ; 2000 Nov; 321(7270):1190-5. PubMed ID: 11073511
[TBL] [Abstract][Full Text] [Related]
12. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
13. Use of combined oral contraceptives and risk of venous thromboembolism: nested case-control studies using the QResearch and CPRD databases.
Vinogradova Y; Coupland C; Hippisley-Cox J
BMJ; 2015 May; 350():h2135. PubMed ID: 26013557
[TBL] [Abstract][Full Text] [Related]
14. Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.
Lancet; 1997 Apr; 349(9060):1202-9. PubMed ID: 9130941
[TBL] [Abstract][Full Text] [Related]
15. Rebuilding confidence in oral contraceptives: a new imperative in family planning.
Spitzer WO
Br J Clin Pharmacol; 1996 May; 41(5):359-63. PubMed ID: 8735675
[TBL] [Abstract][Full Text] [Related]
16. Effect of 1995 pill scare on rates of venous thromboembolism among women taking combined oral contraceptives: analysis of general practice research database.
Farmer RD; Williams TJ; Simpson EL; Nightingale AL
BMJ; 2000 Aug 19-26; 321(7259):477-9. PubMed ID: 10948026
[TBL] [Abstract][Full Text] [Related]
17. Thromboembolic stroke in young women. A European case-control study on oral contraceptives. Transnational Research Group on Oral Contraceptives and the Health of Young Women.
Heinemann LA; Lewis MA; Spitzer WO; Thorogood M; Guggenmoos-Holzmann I; Bruppacher R
Contraception; 1998 Jan; 57(1):29-37. PubMed ID: 9554248
[TBL] [Abstract][Full Text] [Related]
18. Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens.
van Lunsen HW
Eur J Contracept Reprod Health Care; 1996; 1(1):39-45. PubMed ID: 9678136
[TBL] [Abstract][Full Text] [Related]
19. Third generation oral contraceptives and risk of venous thrombosis: meta-analysis.
Kemmeren JM; Algra A; Grobbee DE
BMJ; 2001 Jul; 323(7305):131-4. PubMed ID: 11463678
[TBL] [Abstract][Full Text] [Related]
20. A review of post-marketing safety and surveillance data for oral contraceptives containing norgestimate and ethinyl estradiol.
Lippman JS; Shangold GA
Int J Fertil Womens Med; 1997; 42(4):230-9. PubMed ID: 9309456
[No Abstract] [Full Text] [Related]
[Next] [New Search]
